David Bird
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
David Bird has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Richard Speight
Leeds Teaching Hospitals NHS Trust, Leeds, UK
9 shared publicationsBashar Al-Qaisieh
Leeds Teaching Hospitals NHS Trust, Leeds, UK
8 shared publications- Richard Speight
Department of Medical Physics and Engineering, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, United Kingdom
7 shared publications Alexandra Gilbert
Leeds Teaching Hospitals NHS Trust
4 shared publicationsAnn M. Henry
Leeds Teaching Hospitals NHS Trust
4 shared publications- Bashar Al-Qaisieh
Department of Medical Physics and Engineering, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, United Kingdom
4 shared publications
Latest Publications
- Open Access
- 21 August 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 35, 100328
Clinical validation of using a commercial synthetic-computed tomography solution for brain MRI-only radiotherapy treatment planning
- 21 August 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 35, 100328
Open AccessClinical validation of using a commercial synthetic-computed tomography solution for brain MRI-only radiotherapy treatment planning
- Open Access
- 11 April 2025
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 11 (3) , 035014
Evaluating the dosimetric and positioning accuracy of a deep learning based synthetic-CT model for liver radiotherapy treatment planning
Background and purpose. An MRI-only workflow requires synthetic computed tomography (sCT) images to enable dose calculation. This study evaluated the dosimetric and patient positioning accuracy of deep learning-generated sCT for liver radiotherapy. Methods and materials. sCT images were generated for eleven patients using a CycleGAN algorithm. Clinical volumetric modulated arc treatment plans (VMAT) were calculated on CT and recalculated on sCT, and dose differences were assessed using dose volume histogram (DVH). For position verification, the sCT images were validated as reference images to 4D cone beam computed tomography (4D CBCT) by calculating the translational and rotational differences between sCT and CT registrations to 4D CBCT. Results. The mean dose differences for the planning target volume (PTV) and organs at risk (OAR) between the CT and sCT plans were 0.0% and < 0.5%, respectively. For positioning verification, the systematic translational and rotational differences were < 0.5 mm and < 0.5°, respectively in all directions. Conclusion. This is the first study to validate a sCT model for liver cancer in terms of both dosimetry and patient positioning, marking a significant step in demonstrating the feasibility of an MRI-only workflow for treating liver cancer. The generated sCTs showed dosimetric differences within clinically acceptable levels and were successfully used as reference images for treatment position verification. This CycleGAN model is accessible through the research version of a commercial vendor, with potential for development as a clinical solution.
- 11 April 2025
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 11 (3) , 035014
Open AccessEvaluating the dosimetric and positioning accuracy of a deep learning based synthetic-CT model for liver radiotherapy treatment planning
Background and purpose. An MRI-only workflow requires synthetic computed tomography (sCT) images to enable dose calculation. This study evaluated the dosimetric and patient positioning accuracy of deep learning-generated sCT for liver radiotherapy. Methods and materials. sCT images were generated for eleven patients using a CycleGAN algorithm. Clinical volumetric modulated arc treatment plans (VMAT) were calculated on CT and recalculated on sCT, and dose differences were assessed using dose volume histogram (DVH). For position verification, the sCT images were validated as reference images to 4D cone beam computed tomography (4D CBCT) by calculating the translational and rotational differences between sCT and CT registrations to 4D CBCT. Results. The mean dose differences for the planning target volume (PTV) and organs at risk (OAR) between the CT and sCT plans were 0.0% and < 0.5%, respectively. For positioning verification, the systematic translational and rotational differences were < 0.5 mm and < 0.5°, respectively in all directions. Conclusion. This is the first study to validate a sCT model for liver cancer in terms of both dosimetry and patient positioning, marking a significant step in demonstrating the feasibility of an MRI-only workflow for treating liver cancer. The generated sCTs showed dosimetric differences within clinically acceptable levels and were successfully used as reference images for treatment position verification. This CycleGAN model is accessible through the research version of a commercial vendor, with potential for development as a clinical solution.
- Open Access
- 31 March 2025
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 24, e14
An automated cone-beam CT dosimetric assessment pipeline for adaptive head and neck radiotherapy
Background and purpose: Adaptive radiotherapy (ART) is commonly used to mitigate effects of anatomical change during head and neck (H&N) radiotherapy. The process of identifying patients for ART can be subjective and resource-intensive. This feasibility project aims to design and validate a pipeline to automate the process and use it to assess the current clinical pathway for H&N treatments. Methods: The pipeline analysed patients’ on-set cone-beam CT (CBCT) scans to identify inter-fractional anatomical changes. CBCTs were converted into synthetic CTs, contours were automatically generated, and the original plan was recomputed. Each synthetic CT was evaluated against a set of dosimetric goals, with failed goals causing an ART recommendation. To validate pipeline performance, a ‘gold standard’ was synthesised by recomputing patients’ original plans on a rescan-CT acquired during treatment and identifying failed clinical goals. The pipeline sensitivity and specificity compared to this ‘gold standard’ were calculated for 12 ART patients. The pipeline was then run on a cohort of 12 ART and 14 non-ART patients, and its sensitivity and specificity were instead calculated against the clinical decision made. Results: The pipeline showed good agreement with the synthesised ‘gold standard’ with an optimum sensitivity of 0·83 and specificity of 0·67. When run over a cohort containing both ART and non-ART patients and assessed against the subjective clinical decision made, the pipeline showed no predictive power (sensitivity: 0·58, specificity: 0·47). Conclusions: Good agreement with the ‘gold standard’ gives confidence in pipeline performance and disagreement with clinical decisions implies implementation could help standardise the current clinical pathway.
- 31 March 2025
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 24, e14
Open AccessAn automated cone-beam CT dosimetric assessment pipeline for adaptive head and neck radiotherapy
Background and purpose: Adaptive radiotherapy (ART) is commonly used to mitigate effects of anatomical change during head and neck (H&N) radiotherapy. The process of identifying patients for ART can be subjective and resource-intensive. This feasibility project aims to design and validate a pipeline to automate the process and use it to assess the current clinical pathway for H&N treatments. Methods: The pipeline analysed patients’ on-set cone-beam CT (CBCT) scans to identify inter-fractional anatomical changes. CBCTs were converted into synthetic CTs, contours were automatically generated, and the original plan was recomputed. Each synthetic CT was evaluated against a set of dosimetric goals, with failed goals causing an ART recommendation. To validate pipeline performance, a ‘gold standard’ was synthesised by recomputing patients’ original plans on a rescan-CT acquired during treatment and identifying failed clinical goals. The pipeline sensitivity and specificity compared to this ‘gold standard’ were calculated for 12 ART patients. The pipeline was then run on a cohort of 12 ART and 14 non-ART patients, and its sensitivity and specificity were instead calculated against the clinical decision made. Results: The pipeline showed good agreement with the synthesised ‘gold standard’ with an optimum sensitivity of 0·83 and specificity of 0·67. When run over a cohort containing both ART and non-ART patients and assessed against the subjective clinical decision made, the pipeline showed no predictive power (sensitivity: 0·58, specificity: 0·47). Conclusions: Good agreement with the ‘gold standard’ gives confidence in pipeline performance and disagreement with clinical decisions implies implementation could help standardise the current clinical pathway.
- Open Access
- 9 December 2024
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 23, e29
An automated assessment pipeline to identify prostate treatments that need adaptive radiotherapy
Background and purpose: This project developed and validated an automated pipeline for prostate treatments to accurately determine which patients could benefit from adaptive radiotherapy (ART) using synthetic CTs (sCTs) generated from on-treatment cone-beam CT (CBCT) images. Materials and methods: The automated pipeline converted CBCTs to sCTs utilising deep-learning, for accurate dose recalculation. Deformable image registration mapped contours from the planning CT to the sCT, with the treatment plan recalculated. A pass/fail assessment used relevant clinical goals. A fail threshold indicated ART was required. All acquired CBCTs (230 sCTs) for 31 patients (6 who had ART) were assessed for pipeline accuracy and clinical viability, comparing clinical outcomes to pipeline outcomes. Results: The pipeline distinguished patients requiring ART; 74·4% of sCTs for ART patients were red (failure) results, compared to 6·4% of non-ART sCTs. The receiver operator characteristic area under curve was 0·98, demonstrating high performance. The automated pipeline was statistically significantly (p < 0·05) quicker than the current clinical assessment methods (182·5s and 556·4s, respectively), and deformed contour accuracy was acceptable, with 96·6% of deformed clinical target volumes (CTVs) clinically acceptable. Conclusion: The automated pipeline identified patients who required ART with high accuracy while reducing time and resource requirements. This could reduce departmental workload and increase efficiency and personalisation of patient treatments. Further work aims to apply the pipeline to other treatment sites and investigate its potential for taking into account dose accumulation.
- 9 December 2024
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 23, e29
Open AccessAn automated assessment pipeline to identify prostate treatments that need adaptive radiotherapy
Background and purpose: This project developed and validated an automated pipeline for prostate treatments to accurately determine which patients could benefit from adaptive radiotherapy (ART) using synthetic CTs (sCTs) generated from on-treatment cone-beam CT (CBCT) images. Materials and methods: The automated pipeline converted CBCTs to sCTs utilising deep-learning, for accurate dose recalculation. Deformable image registration mapped contours from the planning CT to the sCT, with the treatment plan recalculated. A pass/fail assessment used relevant clinical goals. A fail threshold indicated ART was required. All acquired CBCTs (230 sCTs) for 31 patients (6 who had ART) were assessed for pipeline accuracy and clinical viability, comparing clinical outcomes to pipeline outcomes. Results: The pipeline distinguished patients requiring ART; 74·4% of sCTs for ART patients were red (failure) results, compared to 6·4% of non-ART sCTs. The receiver operator characteristic area under curve was 0·98, demonstrating high performance. The automated pipeline was statistically significantly (p < 0·05) quicker than the current clinical assessment methods (182·5s and 556·4s, respectively), and deformed contour accuracy was acceptable, with 96·6% of deformed clinical target volumes (CTVs) clinically acceptable. Conclusion: The automated pipeline identified patients who required ART with high accuracy while reducing time and resource requirements. This could reduce departmental workload and increase efficiency and personalisation of patient treatments. Further work aims to apply the pipeline to other treatment sites and investigate its potential for taking into account dose accumulation.
- Open Access
- 28 October 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (21) , 215031
Optimisation of cone beam CT radiotherapy imaging protocols using a novel 3D printed head and neck anthropomorphic phantom
Objective. This study aimed to optimise Cone Beam Computed Tomography (CBCT) protocols for head and neck (H&N) radiotherapy treatments using a 3D printed anthropomorphic phantom. It focused on precise patient positioning in conventional treatment and adaptive radiotherapy (ART). Approach. Ten CBCT protocols were evaluated with the 3D-printed H&N anthropomorphic phantom, including one baseline protocol currently used at our centre and nine new protocols. Adjustments were made to milliamperage and exposure time to explore their impact on radiation dose and image quality. Additionally, the effect on image quality of varying the scatter correction parameter for each of the protocols was assessed. Each protocol was compared against a reference CT scan. Usability was assessed by three Clinical Scientists using a Likert scale, and statistical validation was performed on the findings. Main results. The work revealed variability in the effectiveness of protocols. Protocols optimised for lower radiation exposure maintained sufficient image quality for patient setup in a conventional radiotherapy pathway, suggesting the potential for reducing patient radiation dose by over 50% without compromising efficacy. Optimising ART protocols involves balancing accuracy across brain, bone, and soft tissue, as no single protocol or scatter correction parameter achieves optimal results for all simultaneously. Significance. This study underscores the importance of optimising CBCT protocols in H&N radiotherapy. Our findings highlight the potential to maintain the usability of CBCT for bony registration in patient setup while significantly reducing the radiation dose, emphasizing the significance of optimising imaging protocols for the task in hand (registering to soft tissue or bone) and aligning with the as low as reasonably achievable principle. More studies are needed to assess these protocols for ART, including CBCT dose measurements and CT comparisons. Furthermore, the novel 3D printed anthropomorphic phantom demonstrated to be a useful tool when optimising CBCT protocols.
- 28 October 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (21) , 215031
Open AccessOptimisation of cone beam CT radiotherapy imaging protocols using a novel 3D printed head and neck anthropomorphic phantom
Objective. This study aimed to optimise Cone Beam Computed Tomography (CBCT) protocols for head and neck (H&N) radiotherapy treatments using a 3D printed anthropomorphic phantom. It focused on precise patient positioning in conventional treatment and adaptive radiotherapy (ART). Approach. Ten CBCT protocols were evaluated with the 3D-printed H&N anthropomorphic phantom, including one baseline protocol currently used at our centre and nine new protocols. Adjustments were made to milliamperage and exposure time to explore their impact on radiation dose and image quality. Additionally, the effect on image quality of varying the scatter correction parameter for each of the protocols was assessed. Each protocol was compared against a reference CT scan. Usability was assessed by three Clinical Scientists using a Likert scale, and statistical validation was performed on the findings. Main results. The work revealed variability in the effectiveness of protocols. Protocols optimised for lower radiation exposure maintained sufficient image quality for patient setup in a conventional radiotherapy pathway, suggesting the potential for reducing patient radiation dose by over 50% without compromising efficacy. Optimising ART protocols involves balancing accuracy across brain, bone, and soft tissue, as no single protocol or scatter correction parameter achieves optimal results for all simultaneously. Significance. This study underscores the importance of optimising CBCT protocols in H&N radiotherapy. Our findings highlight the potential to maintain the usability of CBCT for bony registration in patient setup while significantly reducing the radiation dose, emphasizing the significance of optimising imaging protocols for the task in hand (registering to soft tissue or bone) and aligning with the as low as reasonably achievable principle. More studies are needed to assess these protocols for ART, including CBCT dose measurements and CT comparisons. Furthermore, the novel 3D printed anthropomorphic phantom demonstrated to be a useful tool when optimising CBCT protocols.
- Open Access
- 4 July 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 31, 100604
A systematic review of 4D magnetic resonance imaging techniques for abdominal radiotherapy treatment planning
- 4 July 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 31, 100604
Open AccessA systematic review of 4D magnetic resonance imaging techniques for abdominal radiotherapy treatment planning
- 12 December 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 191, 110052
Deep learning MRI-only synthetic-CT generation for pelvis, brain and head and neck cancers
- 12 December 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 191, 110052
Deep learning MRI-only synthetic-CT generation for pelvis, brain and head and neck cancers
- Open Access
- 25 July 2023
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 27, 100476
The role and potential of using quantitative MRI biomarkers for imaging guidance in brain cancer radiotherapy treatment planning: A systematic review
- 25 July 2023
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 27, 100476
Open AccessThe role and potential of using quantitative MRI biomarkers for imaging guidance in brain cancer radiotherapy treatment planning: A systematic review
- Open Access
- 1 December 2022
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 21 (4) , 487-492
Assessing the patient experience of anal and rectal cancer MR simulation for radiotherapy treatment planning
Aim: The patient experience of radiotherapy magnetic resonance (MR) simulation is unknown. This study aims to evaluate the patient experience of MR simulation in comparison to computed tomography (CT) simulation, identifying the quality of patient experience and pathway changes which could improve patient experience outcomes. Materials and Methods: MR simulation was acquired for 46 anal and rectal cancer patients. Patient experience questionnaires were provided directly after MR simulation. Questionnaire responses were assessed after 33 patients (cohort one). Changes to the scanning pathway were identified and implemented. The impact of changes was assessed by cohort two (13 patients). Results: Response rates were 85% (cohort one) and 54% (cohort two). 75% of cohort one respondents found the magnetic resonance imaging (MRI) experience to be better or similar to their CT experience. Implemented changes included routine use of blankets, earplugs and headphones, music and feet-first positioning and further MRI protocol optimisation. All cohort two respondents found the MRI experience to be better or similar to the CT experience. Findings: MR simulation can be a comfortable and positive experience that is comparable to that of standard radiotherapy CT simulation. Special attention is required due to the fundamental differences between CT and MRI scanning.
- 1 December 2022
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 21 (4) , 487-492
Open AccessAssessing the patient experience of anal and rectal cancer MR simulation for radiotherapy treatment planning
Aim: The patient experience of radiotherapy magnetic resonance (MR) simulation is unknown. This study aims to evaluate the patient experience of MR simulation in comparison to computed tomography (CT) simulation, identifying the quality of patient experience and pathway changes which could improve patient experience outcomes. Materials and Methods: MR simulation was acquired for 46 anal and rectal cancer patients. Patient experience questionnaires were provided directly after MR simulation. Questionnaire responses were assessed after 33 patients (cohort one). Changes to the scanning pathway were identified and implemented. The impact of changes was assessed by cohort two (13 patients). Results: Response rates were 85% (cohort one) and 54% (cohort two). 75% of cohort one respondents found the magnetic resonance imaging (MRI) experience to be better or similar to their CT experience. Implemented changes included routine use of blankets, earplugs and headphones, music and feet-first positioning and further MRI protocol optimisation. All cohort two respondents found the MRI experience to be better or similar to the CT experience. Findings: MR simulation can be a comfortable and positive experience that is comparable to that of standard radiotherapy CT simulation. Special attention is required due to the fundamental differences between CT and MRI scanning.
- Open Access
- 22 October 2021
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 22 (11) , 41-53
The benefit of MR‐only radiotherapy treatment planning for anal and rectal cancers: A planning study
Introduction Limited evidence exists showing the benefit of magnetic resonance (MR)-only radiotherapy treatment planning for anal and rectal cancers. This study aims to assess the impact of MR-only planning on target volumes (TVs) and treatment plan doses to organs at risks (OARs) for anal and rectal cancers versus a computed tomography (CT)-only pathway. Materials and methods Forty-six patients (29 rectum and 17 anus) undergoing preoperative or radical external beam radiotherapy received CT and T2 MR simulation. TV and OARs were delineated on CT and MR, and volumetric arc therapy treatment plans were optimized independently (53.2 Gy/28 fractions for anus, 45 Gy/25 fractions for rectum). Further treatment plans assessed gross tumor volume (GTV) dose escalation. Differences in TV volumes and OAR doses, in terms of Vx Gy (organ volume (%) receiving x dose (Gy)), were assessed. Results MR GTV and primary planning TV (PTV) volumes systematically reduced by 13 cc and 98 cc (anus) and 44 cc and 109 cc (rectum) respectively compared to CT volumes. Statistically significant OAR dose reductions versus CT were found for bladder and uterus (rectum) and bladder, penile bulb, and genitalia (anus). With GTV boosting, statistically significant dose reductions were found for sigmoid, small bowel, vagina, and penile bulb (rectum) and vagina (anus). Conclusion Our findings provide evidence that the introduction of MR (whether through MR-only or CT-MR pathways) to radiotherapy treatment planning for anal and rectal cancers has the potential to improve treatments. MR-related OAR dose reductions may translate into less treatment-related toxicity for patients or greater ability to dose escalate.
- 22 October 2021
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 22 (11) , 41-53
Open AccessThe benefit of MR‐only radiotherapy treatment planning for anal and rectal cancers: A planning study
Introduction Limited evidence exists showing the benefit of magnetic resonance (MR)-only radiotherapy treatment planning for anal and rectal cancers. This study aims to assess the impact of MR-only planning on target volumes (TVs) and treatment plan doses to organs at risks (OARs) for anal and rectal cancers versus a computed tomography (CT)-only pathway. Materials and methods Forty-six patients (29 rectum and 17 anus) undergoing preoperative or radical external beam radiotherapy received CT and T2 MR simulation. TV and OARs were delineated on CT and MR, and volumetric arc therapy treatment plans were optimized independently (53.2 Gy/28 fractions for anus, 45 Gy/25 fractions for rectum). Further treatment plans assessed gross tumor volume (GTV) dose escalation. Differences in TV volumes and OAR doses, in terms of Vx Gy (organ volume (%) receiving x dose (Gy)), were assessed. Results MR GTV and primary planning TV (PTV) volumes systematically reduced by 13 cc and 98 cc (anus) and 44 cc and 109 cc (rectum) respectively compared to CT volumes. Statistically significant OAR dose reductions versus CT were found for bladder and uterus (rectum) and bladder, penile bulb, and genitalia (anus). With GTV boosting, statistically significant dose reductions were found for sigmoid, small bowel, vagina, and penile bulb (rectum) and vagina (anus). Conclusion Our findings provide evidence that the introduction of MR (whether through MR-only or CT-MR pathways) to radiotherapy treatment planning for anal and rectal cancers has the potential to improve treatments. MR-related OAR dose reductions may translate into less treatment-related toxicity for patients or greater ability to dose escalate.